Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost effective strategy in spondyloarthritis

Dubash, S orcid.org/0000-0002-9303-7122, Bryer, D, Fitton, J et al. (4 more authors) (2018) Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost effective strategy in spondyloarthritis. In: Eleventh International Congress on Spondyloarthritides, 04-06 Oct 2018, Gent, Belgium.

Metadata

Authors/Creators:
Dates:
  • Published: April 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 06 Nov 2020 15:17
Last Modified: 06 Nov 2020 15:31
Status: Published
Identification Number: https://doi.org/10.1093/rheumatology/key075.289
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics